SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome

Leanne Dibbens1, Michael Schwake2, Paul Saftig3

  • 1Epilepsy Research Group, School of Pharmacy and Medical Sciences, University of South Australia, and Sansom Institute for Health Research, South Australia, Australia.

Insights

Action myoclonus-renal failure syndrome (AMRF) is a genetic epilepsy linked to SCARB2 gene mutations. This overview details its clinical and genetic aspects, including neurological symptoms and LIMP2 protein functions.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Action myoclonus-renal failure syndrome (AMRF) is a rare, inherited neurological disorder.
  • It is characterized by progressive myoclonus epilepsy (PME) and renal dysfunction.
  • AMRF arises from loss-of-function mutations in the SCARB2 gene, which encodes lysosomal integral membrane protein type 2 (LIMP2).

Purpose of the Study:

  • To provide an updated overview of SCARB2-related PME.
  • To summarize the clinical and genetic features of this condition.
  • To discuss the known functions of the LIMP2 protein.

Main Methods:

  • Literature review of clinical cases and genetic studies.
  • Analysis of SCARB2 gene mutations and their impact.
  • Review of LIMP2 protein functions in cellular pathways.

Main Results:

  • SCARB2 mutations cause PME, sometimes without renal compromise.
  • Neurological manifestations include peripheral neuropathy, hearing loss, and dementia.
  • The disease course is relentlessly progressive.

Conclusions:

  • SCARB2-related PME is a distinct PME subtype with a variable clinical spectrum.
  • Understanding LIMP2 protein function is crucial for elucidating disease mechanisms.
  • Further research is needed to explore therapeutic strategies for SCARB2-related PME.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
726
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K